Patent US7574661B2 successfully refreshed from Google Patents.
Patent EP0371437A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0371437A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Method and reagent combination for determining nucleotide sequences

Assignee: Sangtec Molecular Diagnostics AB
•
Filing: 1989-11-28
•
Granted: —
•
Expires: 2009-11-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides for detection of changes in a nucleotide sequence based on the determination of the nucleotide sequence over the region of interest. The first step of the process involves obtaining an amplified DNA sample in which at least one attachment moiety has been introduced into at least one strand of a target polynucleo­tide by a modified polymerase chain reaction. This can be accomplished by synthesizing DNA using the target nucleic acid polymer as a template and using at least one amplifica­tion primer, which includes an attachment moiety bonded to the oligonucleotide. The resulting amplification mixture is repeatedly cycled between a polymerization condition and a denaturation condition occurs for a number of cycles suffi­cient to produce copies of the target nucleic acid polymer in a quantity suitable for use in a DNA sequencing procedure to form an amplified sample comprising copies of the target nucleic acid sequence bonded to the attachment moiety. After amplification, the strands of target nucleic acid polymer carrying an attachment moiety are captured using a solid matrix coated with an attachment site to which the attachment moiety or a modification thereof can bind. In this way, the strands of target nucleic acid become bound to the solid matrix and can be readily separated with the solid matrix from unbound reactants for sequencing.

Inventors

  • 👤 Hans Erik Söderland
  • 👤 Ann-Christine Elizabeth Syvänen

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-02 23:42
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6869; C12Q1/6813; C12Q1/6844; C12Q1/6853; C12Q1/686

Claims Analysis

Total Claims: 36
Claim 1
Independent Claim 279 words
A method for determining the sequence of a target nucleic acid polymer comprising: (a) combining a sample containing the target nucleic acid polymer with a mixture of nucleoside triphosphates, a nucleic acid polymerase, and first and second amplification primers, each amplification primer comprising an oligonucleotide having a region that is complementary to the hybridizes with a different strand of the target nucleic acid polymer and being effective as a primer for nucleic acid polymerization by the nucleic acid polymerase to form an amplification mixture, wherein said first amplification primer further comprises a first attachment moiety bonded to the oligonucleotide; (b) repeatedly cycling the amplification mixture between a first condition under which DNA polymerization occurs and a second condition under which denaturation of double stranded DNA to single stranded DNA occurs for a number of cycles sufficient to produce copies of the target nucleic acid polymer in a quantity suitable for use in a DNA sequencing procedure to form an amplified sample comprising copies of the target nucleic acid sequence bonded to the attachment moiety; (c) adding to the amplified sample a plurality of first supports, each comprising a solid matrix and a first attachment site which is capable of immobilizing one strand of the target nucleic acid polymer through the first attachment moiety; (d) allowing the first attachment sites to interact with the first attachment moieties such that the copies of the target nucleic acid in the amplified sample are immobilized on the first supports; (e) separating the immobilized nucleic acids from the amplification mixture; (f) denaturing the amplified nucleic acid sample to form single stranded nucleic acids; and (g) determining the sequence of the single stranded nucleic acids.
Claim 2
Independent Claim 279 words
A method for determining the sequence of a target nucleic acid polymer comprising: (a) combining a sample containing the target nucleic acid polymer with a mixture of nucleoside triphosphates, a nucleic acid polymerase, and first and second amplification primers, each amplification primer comprising an oligonucleotide having a region that is complementary to the hybridizes with a different strand of the target nucleic acid polymer and being effective as a primer for nucleic acid polymerization by the nucleic acid polymerase to form an amplification mixture, wherein said first amplification primer further comprises a first attachment moiety bonded to the oligonucleotide; (b) repeatedly cycling the amplification mixture between a first condition under which DNA polymerization occurs and a second condition under which denaturation of double stranded DNA to single stranded DNA occurs for a number of cycles sufficient to produce copies of the target nucleic acid polymer in a quantity suitable for use in a DNA sequencing procedure to form an amplified sample comprising copies of the target nucleic acid sequence bonded to the attachment moiety; (c) adding to the amplified sample a plurality of first supports, each comprising a solid matrix and a first attachment site which is capable of immobilizing one strand of the target nucleic acid polymer through the first attachment moiety; (d) allowing the first attachment sites to interact with the first attachment moieties such that the copies of the target nucleic acid in the amplified sample are immobilized on the first supports; (e) separating the immobilized nucleic acids from the amplification mixture; (f) denaturing the amplified nucleic acid sample to form single stranded nucleic acids; and (g) determining the sequence of the single stranded nucleic acids.
Claim 3
Dependent Claim 29 words
A method according to claim 1, wherein the step of denaturing the amplified sample is performed prior to immobilizing the copies of the target nucleic acid on the support.
Claim 4
Dependent Claim 25 words
A method according to claim 1 or 2, wherein the sequence of the single stranded immobilized nucleic acids is determined using a chain termination method.
Claim 5
Independent Claim 27 words
A method according to any one of claims 1 to 3, wherein said first attachment moiety and said first attachment site are components of an affinity pair.
Claim 6
Dependent Claim 24 words
A method according to claim 4, wherein the affinity pair is selected from the group consisting of biotin/avidin, biotin/streptavidin, poly-dA/poly-dT, poly-­dG/poly-dC, hapten/antibody and metal/chelate.
Claim 7
Independent Claim 27 words
A method according to any one of claims 1 to 5, wherein said second amplification primer comprises a second attachment moiety different from said first attachment moiety.
Claim 8
Dependent Claim 46 words
A method according to claim 6, further comprising the step of adding to the amplified sample a plurality of second supports comprising a support matrix and a second attachment site capable of immobilizing one strand of the target nucleic acid polymer through the second attachment moiety.
Claim 9
Dependent Claim 24 words
A method according to claim 6 or 7, wherein said second attachment moiety and said second attachment site are components of an affinity pair.
Claim 10
Dependent Claim 24 words
A method according to claim 8, wherein the affinity pair is selected from the group consisting of biotin/avidin, biotin/streptavidin, poly-dA/poly-dT, poly-­dG/poly-dC, hapten/antibody and metal/chelate.
Claim 11
Independent Claim 36 words
A method according to any one of claims 6 to 9, wherein said first and second supports are concurrently present in the amplified sample and are selected so as to be physically separable from each other.
Claim 12
Dependent Claim 16 words
A method according to claim 10, wherein one of said first and second supports are magnetic.
Claim 13
Dependent Claim 19 words
A method according to claim 10, wherein one or both of said first and second supports is a dipstick.
Claim 14
Independent Claim 165 words
A method according to any one of claims 1 to 12, wherein the sequence-determination process includes the steps of combining the single-stranded immobilized nucleic acids with a sequencing primer and a sequencing mixture comprising nucleoside triphosphates, one chain terminating nucleotide, a polynucleotide synthesizing enzyme and a labeling moiety which is incorporated during nucleic acid synthesis; allowing polymerization to occur for a period of time sufficient for enough chain termination events to occur to permit determination of the sequence to form a partially polymerized sample; adding a completion reagent comprising a mixture of nucleoside triphosphates to the partially polymerized sample; allowing polymerization to occur in the completion reagent for a period of time sufficient to substantially complete DNA synthesis; separating the completely polymerized sample from the completion reagent; releasing the polymerized nucleic acids from the support; denaturing the polymerized nucleic acids to render them single stranded; analyzing the size of the single stranded nucleic acid polymers to determine the sequence of the target nucleic acid polymer.
Claim 15
Dependent Claim 61 words
A method according to claim 13, wherein the sequencing primer is an oligonucleotide selected from among oligonucleotides complementary with at least a portion of the amplification primer and oligonucleotides complementary with a portion of the target nucleic acid polymer which is located between the 3′ end of the amplification primer and a region of interest in the target nucleic acid polymer.
Claim 16
Independent Claim 34 words
A method according to any one of claims 1 to 14, further comprising the step of incubating the amplification mixture at a temperature selected to promote annealing of nucleic acids before each polymerization step.
Claim 17
Dependent Claim 92 words
A kit for use in determining the sequence of a target nucleic acid polymer comprising in packaged combination (a) a first amplification primer comprising an oligonucleotide which is complementary to and hybridizes with a portion of the target nucleic acid polymer and which is effective as a primer for enzymatic nucleic acid polymerization and a first attachment moiety; and (b) a plurality of first supports, each comprising a solid matrix and at least one attachment site which is capable of immobilizing the oligonucleotide of the amplification probe through the first attachment moiety.
Claim 18
Dependent Claim 92 words
A kit for use in determining the sequence of a target nucleic acid polymer comprising in packaged combination (a) a first amplification primer comprising an oligonucleotide which is complementary to and hybridizes with a portion of the target nucleic acid polymer and which is effective as a primer for enzymatic nucleic acid polymerization and a first attachment moiety; and (b) a plurality of first supports, each comprising a solid matrix and at least one attachment site which is capable of immobilizing the oligonucleotide of the amplification probe through the first attachment moiety.
Claim 19
Dependent Claim 20 words
A kit according to claim 16, wherein the attachment moiety and the attachment site are components of an affinity pair.
Claim 20
Dependent Claim 24 words
A kit according to claim 17, wherein the affinity pair is selected from the group consisting of biotin/avidin, biotin/streptavidin, poly-dA/poly-dT, poly-­dG/poly-dC, hapten/antibody and metal/chelate.
Claim 21
Dependent Claim 45 words
A kit according to any one of claims 16 to 18, wherein the attachment moiety does not form a bond directly with the attachment site, further comprising a linking moiety selected so as to form a bond between the attachment moiety and the attachment site.
Claim 22
Dependent Claim 71 words
A kit according to any one of claims 16 to 19, further com­prising a sequencing primer wherein the sequencing primer is an oligonucleotide selected from among oligonucleotides complementary with at least a portion of the amplification primer and oligonucleotides complementary with a portion of the target nucleic acid polymer which is located between the 3′ end of the amplification primer and a region of interest in the target nucleic acid polymer.
Claim 23
Dependent Claim 15 words
A kit according to claim 20, wherein the sequencing primer further comprises a detectable label.
Claim 24
Dependent Claim 33 words
Akit according to any one of claims 16 to 21, further com­prising a reference means for comparison of the determined sequence of the target nucleic acid polymer with the sequence of a standard.
Claim 25
Dependent Claim 24 words
A kit according to claim 22, wherein the reference means is a package insert showing the sequencing ladder obtained from sequencing of the standard.
Claim 26
Dependent Claim 16 words
A kit according to claim 22, wherein the reference means is a sample of the standard.
Claim 27
Dependent Claim 43 words
A kit according to any one of claims 16 to 19 or 22 to 24, wherein the oligonucleotide of the amplification primer is complementary to and hybridizes with a portion of the target nucleic acid polymer which is derived from a target organism.
Claim 28
Dependent Claim 95 words
A kit according to any one of claims 16 to 25, further com­prising a second amplification primer comprising an oligonucleotide which is complementary to and hybridizes with a portion of the second strand of the target nucleic acid polymer and which is effective as a primer for enzymatic nucleic acid polymerization and a second attachment moiety different from the first attachment moiety; and a plurality of second supports each comprising a solid matrix and at least one attachment site which is capable of immobilizing the oligonucleotide of the amplification probe through the second attachment moiety.
Claim 29
Dependent Claim 20 words
A kit according to claim 26, wherein the attachment moiety and the attachment site are components of an affinity pair.
Claim 30
Dependent Claim 26 words
A kit according to claim 26 or 27 wherein the affinity pair is selected from the group consisting of biotin/avidin, biotin/streptavidin, poly-dA/poly-dT, poly-dG/poly-dC, hapten/antibody and metal/chelate.
Claim 31
Dependent Claim 34 words
A kit according to any one of claims 26 to 28, further com­prising a reference means for comparison of the determined sequence of the target nucleic acid polymer with the sequence of a standard.
Claim 32
Independent Claim 24 words
The method according to anyone of claims 1 to 15 for de­termining in the target nucleic acid polymer at least one potential nucleotide variation.
Claim 33
Dependent Claim 18 words
The method according to claim 30 for forensic analysis or for the analysis of hereditary predispositions or diseases.
Claim 34
Dependent Claim 16 words
The method according to claim 30 or 31 wherein the nucleotide variation is a somatic mutation.
Claim 35
Dependent Claim 32 words
The method according to claim 30 or 31 for the selection of cells and strains or species for plant an animal breeding or for the selection of microorganisms dis­playing a desired genotype.
Claim 36
Dependent Claim 23 words
The kit according to anyone of claims 16 to 29 for use in a method according to anyone of claims 30 to 33.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag